Skip to main content
. 2021 Nov 22;2021:6642171. doi: 10.1155/2021/6642171

Figure 2.

Figure 2

(a) The results of ESI-Q-Exactive-Orbitrap MS in positive/negative ion mode; (b) relative cell viability of HGC27 cells treated with/without SQYZD (0, 2, 4, and 8 mg/ml); (c) colony formation capacity of the HGC27 cells treated with/without SQYZD (0, 2, 4, and 8 mg/ml); (d) apoptosis assessed using a TUNEL assay (TUNEL-positive cells indicated in red) (magnification, ×200); (e) and (f) Expression of apoptosis-related proteins examined using western blots after treatment with/without SQYZD (0, 2, 4, and 8 mg/ml).